Back to search

Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.

Data up to Jan 2025

Published1996
Citations47
References31

Total Citations Per Year

Abstract

References (31)

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

1981 • 14,396 citations

Genetic Alterations during Colorectal-Tumor Development

1988 • 6,691 citations

The Papanicolaou Test for Cervical Cancer Detection

1989 • 664 citations

Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment.

1994 • 507 citations

The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses

1995 • 374 citations

The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses: Developed and approved at the national cancer institute workshop in Bethesda, MD, December 12–13, 1988

1989 • 297 citations

The molecular biology of carcinogenesis

1993 • 223 citations

Behavior of moderate cervical dysplasia during long-term follow-up.

1983 • 222 citations

Expression of MaTu‐MN protein in human tumor cultures and in clinical specimens

1993 • 209 citations

Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas.

1994 • 187 citations

Cervical (pap) smear: New directions

1993 • 143 citations

Adenocarcinoma In Situ of the Cervix

1984 • 141 citations

Management and Follow-up of Patients with Adenocarcinoma in Situ of the Uterine Cervix

1995 • 116 citations

The bethesda system for reporting cervical/vaginal cytologic diagnoses: Report of the 1991 bethesda workshop

1992 • 115 citations

Adenocarcinoma in situ of the uterine cervix: A clinico-pathologic study of 36 cases

1989 • 112 citations

The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. I. Adenocarcinoma in situ.

1987 • 97 citations

A binary (Bethesda) system for classifying cervical cancer precursors: Criteria, reproducibility, and viral correlates

1993 • 94 citations

Adenocarcinoma In Situ of the Uterine Cervix

2001 • 93 citations

Abnormal Endocervical Cells:Really Abnormal? Really Endocervical?

1994 • 75 citations

Dysplasia of the cervix

1968 • 68 citations

Comparative cytologic features of adenocarcinoma in situ of the uterine cervix.

1991 • 66 citations

Endocervical Glandular Atypia and Adenocarcinoma

1993 • 64 citations

The Bethesda Classification for Squamous Intraepithelial Lesions

1992 • 56 citations

Improving accuracy in gynecologic cytology. Results of the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.

1993 • 54 citations

The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. III. Pitfalls in diagnosis.

1988 • 53 citations

Characterization of subcolumnar reserve cells and other epithelia of human uterine cervix

1987 • 40 citations

Cervical cancer after initial negative and atypical vaginal cytology

1970 • 40 citations

Laboratory reliability of the Papanicolaou smear.

1985 • 31 citations

Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia.

1994 • 28 citations

In vitro and in vivo analysis of cellular origin of cervical squamous metaplasia.

1993 • 27 citations

Early-stage squamous cell and adenocarcinoma of the cervix

1992 • 8 citations

Cited By (0)

No citing papers found in database

Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic… (1996) – PubMed | Metascience Observatory Explorer